Travere Therapeutics Inc.

19.75
-1.65 (-7.71%)
At close: Mar 03, 2025, 3:59 PM
19.80
0.28%
After-hours: Mar 03, 2025, 04:05 PM EST

Travere Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08
PE Ratio -4.27 -5.99 -4.81 -10.31 -7.65 -4.11 -8.91 -13.68 -14.62 5.52 -2.76 -2.94 -0.4 -10.79 n/a n/a -7.88K
PEG Ratio -0.02 0.09 -0.11 0.67 -2.65 -0.11 -0.14 -0.71 0.11 -0.03 -0.03 0.04 -0.00 n/a n/a n/a n/a
PS Ratio 5.89 4.60 6.32 8.16 6.53 3.43 5.57 5.27 5.24 6.48 10.87 n/a n/a n/a n/a n/a n/a
PB Ratio 23.26 3.32 31.29 6.15 6.13 2.72 2.87 2.79 2.28 2.16 -8.23 -5.42 -3.6 -2.54 n/a n/a 143.87M
P/FCF Ratio -4.06 -2.07 -6.24 -47.69 -7.97 -8.15 -20.48 -123.66 -51.8 -85.36 -6.15 -4.29 -3.12 -3.27K n/a n/a -7.88K
P/OCF Ratio -5.79 -2.38 -7.2 -125.55 -30.31 -10.33 -36.65 110.34 -438.83 -1.17K -6.69 -5.65 -4.48 -3.27K n/a n/a -7.88K
OCF/S Ratio -1.02 -1.93 -0.88 -0.07 -0.22 -0.33 -0.15 0.05 -0.01 -0.01 -1.63 n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 6.80 2.02 9.51 0.87 1.02 0.93 0.68 0.15 0.14 0.15 -2.25 n/a -0.26 -0.4 -0.41 n/a 4.17K
Quick Ratio 2.04 3.41 3.37 4.64 4.35 4.43 4.68 3.74 3.96 3.49 0.34 0.21 0.01 0.06 0.06 n/a 0.14
Current Ratio 2.08 3.47 3.42 4.70 4.43 4.50 4.74 3.80 3.99 3.52 0.35 0.21 0.01 0.06 0.06 n/a 0.14
Asset Turnover 0.39 0.18 0.32 0.29 0.33 0.29 0.23 0.30 0.25 0.19 0.21 n/a n/a n/a n/a n/a n/a
Interest Coverage -28.67 -33.24 -22.31 -6.93 -3.96 -5.3 -8.16 -45.28 -1.69 n/a n/a -1.23 -285.46 -6.41 n/a n/a n/a
Return on Equity (ROE) -5.44 -0.55 -6.5 -0.6 -0.8 -0.66 -0.32 -0.2 -0.16 0.39 2.98 1.85 8.90 0.24 n/a n/a -18.27K
Return on Assets (ROA) -0.54 -0.14 -0.41 -0.23 -0.28 -0.24 -0.14 -0.11 -0.09 0.23 -0.82 -1.65 -12.69 -3.79 n/a n/a -3.83
Return on Capital (ROIC) -0.82 -0.62 -0.47 -0.21 -0.15 -0.2 -0.13 -0.12 -0.13 -0.12 -2.86 1.63 8.87 0.20 n/a n/a 0.63
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 92.12% 96.42% 97.02% 96.91% 97.01% 96.63% 97.67% 96.59% 97.81% 97.98% n/a n/a n/a n/a n/a n/a
Net Profit Margin -137.9% -76.7% -131.35% -79.16% -85.43% -83.51% -62.51% -38.55% -35.86% 117.36% -393.35% n/a n/a n/a n/a n/a n/a
Pretax Profit Margin -137.45% -258.96% -131.2% -78.98% -95.19% -83.52% -62.02% -37.67% -43.1% 105.58% -402.07% n/a n/a n/a n/a n/a n/a
Operating Profit Margin -137.51% -259.4% -118.65% -61.32% -38.01% -56.92% -48.73% -34.72% -43.58% -50.8% -282.97% n/a n/a n/a n/a n/a n/a
FCF Margin -145.25% -221.9% -101.33% -17.12% -81.98% -42.08% -27.19% -4.26% -10.12% -7.59% -176.62% n/a n/a n/a n/a n/a n/a
EBITDA Margin -113.98% -224.63% -141.22% -82.06% -72.59% -61.15% -44.68% -24.96% -29.03% 129.60% -262.76% n/a n/a n/a n/a n/a n/a